Heritability of MRI Lesion Volume in CADASIL Evidence for Genetic Modifiers
Background and Purpose— The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3 . However, little is known about the factor...
Saved in:
Published in | Stroke (1970) Vol. 37; no. 11; pp. 2684 - 2689 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
01.11.2006
|
Subjects | |
Online Access | Get full text |
ISSN | 0039-2499 1524-4628 1524-4628 |
DOI | 10.1161/01.STR.0000245084.35575.66 |
Cover
Loading…
Abstract | Background and Purpose—
The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in
NOTCH3
. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions.
Methods—
One hundred and fifty-one affected individuals (mean age±SD=45.7±10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates.
Results—
In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all
P
<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=±0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE±0.255).
Conclusions—
Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative
NOTCH3
mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression. |
---|---|
AbstractList | The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions.
One hundred and fifty-one affected individuals (mean age+/-SD=45.7+/-10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates.
In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=+/-0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE+/-0.255).
Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression. BACKGROUND: and Purpose- The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions. METHODS: One hundred and fifty-one affected individuals (mean age plus or minus SD=45.7 plus or minus 10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates. RESULTS: In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE= plus or minus 0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE plus or minus 0.255). CONCLUSIONS: Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression. Background and Purpose— The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3 . However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions. Methods— One hundred and fifty-one affected individuals (mean age±SD=45.7±10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates. Results— In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P <0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=±0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE±0.255). Conclusions— Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression. The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions.BACKGROUND AND PURPOSEThe phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions.One hundred and fifty-one affected individuals (mean age+/-SD=45.7+/-10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates.METHODSOne hundred and fifty-one affected individuals (mean age+/-SD=45.7+/-10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates.In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=+/-0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE+/-0.255).RESULTSIn multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=+/-0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE+/-0.255).Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression.CONCLUSIONSHeritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression. |
Author | Peters, Nils Opherk, Christian Müller-Myhsok, Bertram Gschwendtner, Andreas Holtmannspötter, Markus Dichgans, Martin |
Author_xml | – sequence: 1 givenname: Christian surname: Opherk fullname: Opherk, Christian organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany – sequence: 2 givenname: Nils surname: Peters fullname: Peters, Nils organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany – sequence: 3 givenname: Markus surname: Holtmannspötter fullname: Holtmannspötter, Markus organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany – sequence: 4 givenname: Andreas surname: Gschwendtner fullname: Gschwendtner, Andreas organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany – sequence: 5 givenname: Bertram surname: Müller-Myhsok fullname: Müller-Myhsok, Bertram organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany – sequence: 6 givenname: Martin surname: Dichgans fullname: Dichgans, Martin organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18266901$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17008614$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtPwzAQhC0EgvL4CyhCghMJXmftOJyoyqtSEVILXC3HcSSjPEqcHPrvSaFQiQt72cu3M6uZQ7JbN7Ul5AxoBCDgikK0eJlHdBiGnEqMYs4THgmxQ0bAGYYomNwlI0rjNGSYpgfk0Pv3NR9Lvk8OIKFUCsARuXy0ret05krXrYKmCJ7m02BmvWvq4K0p-8oGrg4m49vxYjo7JnuFLr092ewj8np_9zJ5DGfPD9PJeBYaBN6FhtoMDUgpIcvjVIAGHNxybRGlZELoBI1INLUosEh4lgNiYiyjzMTIZHxELr51l23z0Vvfqcp5Y8tS17bpvRIpZSAo_xeENOZpItaKpxuwzyqbq2XrKt2u1E8QA3C-AbQ3uixaXRvnt9z67ZTCwN18c6ZtvG9tocwQXzfE1bXalQqoWnekKKihI7XtSH11pIQYJK7_SPy6_H_8CVczkag |
CODEN | SJCCA7 |
CitedBy_id | crossref_primary_10_1016_j_jns_2016_05_061 crossref_primary_10_1007_s12975_010_0041_5 crossref_primary_10_1161_CIRCRESAHA_122_319950 crossref_primary_10_1007_s00415_009_5048_z crossref_primary_10_1016_j_neulet_2009_06_087 crossref_primary_10_1016_j_neurobiolaging_2014_08_021 crossref_primary_10_1212_WNL_0000000000002263 crossref_primary_10_1016_S1474_4422_07_70028_5 crossref_primary_10_1097_YCO_0b013e3282f945d5 crossref_primary_10_4199_C00052ED1V01Y201204GMM001 crossref_primary_10_1007_s00108_009_2469_9 crossref_primary_10_1161_STROKEAHA_122_039325 crossref_primary_10_1038_jcbfm_2015_71 crossref_primary_10_1212_01_wnl_0000339038_65508_96 crossref_primary_10_1016_j_neurobiolaging_2022_11_013 crossref_primary_10_1007_s00415_015_7794_4 crossref_primary_10_1055_s_0043_1769618 crossref_primary_10_1136_jnnp_2020_325838 crossref_primary_10_1161_STROKEAHA_114_006849 crossref_primary_10_1111_j_1468_2982_2009_01940_x crossref_primary_10_1111_j_1552_6569_2008_00336_x crossref_primary_10_1093_hmg_ddr345 crossref_primary_10_1001_jamaneurol_2022_3832 crossref_primary_10_1212_WNL_0000000000200744 crossref_primary_10_1016_j_jpsychires_2010_04_019 crossref_primary_10_1111_j_1755_5949_2010_00181_x crossref_primary_10_1001_jamaneurol_2022_3994 crossref_primary_10_1093_hmg_ddz285 crossref_primary_10_1161_JAHA_123_035771 crossref_primary_10_1212_01_CON_0000396959_52198_1b crossref_primary_10_1111_head_12169 crossref_primary_10_1186_s12916_017_0778_8 crossref_primary_10_1192_apt_bp_107_004655 crossref_primary_10_1371_journal_pmed_1000225 crossref_primary_10_1177_0333102410384637 crossref_primary_10_1111_ane_12400 crossref_primary_10_1007_s12035_018_1055_3 crossref_primary_10_1016_j_ebiom_2024_105297 |
Cites_doi | 10.1093/brain/114.2.761 10.1007/s004150050083 10.1161/01.str.0000196987.68770.b3 10.1212/WNL.56.5.673 10.1093/brain/awh586 10.1093/brain/awh223 10.1136/jnnp.54.8.683 10.1212/01.wnl.0000216271.96364.50 10.1161/01.str.0000129643.77045.10 10.1212/WNL.43.9.1683 10.1212/WNL.51.2.452 10.1161/hyp.38.1.110 10.1056/NEJMoa051469 10.1001/archneur.62.7.1091 10.1086/302698 10.1161/circulationaha.104.501163 10.1161/str.17.6.3810706 10.1038/ng786 10.1161/str.29.6.1177 10.1161/01.str.0000189696.70989.a4 10.1073/pnas.0308679101 10.1161/str.26.7.1293 10.1038/ng1533 10.1007/s004010100439 10.1016/S0140-6736(97)08083-5 10.1161/str.27.8.1274 10.1097/00005072-199709000-00001 10.1161/str.28.3.652 10.1002/ana.410440506 10.1212/WNL.52.7.1361 10.1093/brain/awh023 10.1006/nimg.2002.1040 10.1016/S0021-9150(02)00041-2 10.1161/01.str.0000177867.39769.cb 10.1161/01.hyp.0000112303.26158.92 10.1038/383707a0 10.1016/S0140-6736(95)91557-5 10.1212/WNL.45.5.883 10.1161/01.str.0000131546.71733.f1 10.1007/s004150050398 10.1148/radiol.2293021354 10.1161/hyp.39.2.343 10.1093/brain/awh282 |
ContentType | Journal Article |
Copyright | 2006 INIST-CNRS |
Copyright_xml | – notice: 2006 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 P64 RC3 7X8 |
DOI | 10.1161/01.STR.0000245084.35575.66 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Engineering Research Database Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Genetics Abstracts CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
EndPage | 2689 |
ExternalDocumentID | 17008614 18266901 10_1161_01_STR_0000245084_35575_66 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3C .55 .GJ .XZ .Z2 01R 0R~ 123 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ A9M AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAUEB AAXQO AAYEP AAYJJ AAYXX ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFS ACGOD ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADGHP ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BCGUY BOYCO BQLVK BS7 C45 CITATION CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B M18 N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YQJ YYP ZB8 ZGI ZZMQN IQODW ACIJW AWKKM CGR CUY CVF ECM EIF NPM OJAPA OLW RHF YCJ 7TK 8FD FR3 P64 RC3 7X8 |
ID | FETCH-LOGICAL-c415t-c0eb4c18881bd3961a14861dae4488266a74c67a0e464f75bd1447ce202c34283 |
ISSN | 0039-2499 1524-4628 |
IngestDate | Fri Jul 11 00:43:42 EDT 2025 Fri Jul 11 04:41:26 EDT 2025 Wed Feb 19 01:44:01 EST 2025 Mon Jul 21 09:16:12 EDT 2025 Tue Jul 01 03:03:39 EDT 2025 Thu Apr 24 23:12:01 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Stroke Nervous system diseases white matter hyperintensities Cardiovascular disease Nuclear magnetic resonance imaging White matter Cerebral disorder Vascular disease CADASIL genetics Central nervous system disease CADASIL syndrome Cerebrovascular disease Hyperintensity |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c415t-c0eb4c18881bd3961a14861dae4488266a74c67a0e464f75bd1447ce202c34283 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 17008614 |
PQID | 19359768 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_69021605 proquest_miscellaneous_19359768 pubmed_primary_17008614 pascalfrancis_primary_18266901 crossref_citationtrail_10_1161_01_STR_0000245084_35575_66 crossref_primary_10_1161_01_STR_0000245084_35575_66 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-11-01 |
PublicationDateYYYYMMDD | 2006-11-01 |
PublicationDate_xml | – month: 11 year: 2006 text: 2006-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Stroke (1970) |
PublicationTitleAlternate | Stroke |
PublicationYear | 2006 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 (e_1_3_2_41_2) 2005; 26 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_25_2 (e_1_3_2_33_2) 2006; 27 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 |
References_xml | – ident: e_1_3_2_27_2 doi: 10.1093/brain/114.2.761 – ident: e_1_3_2_16_2 doi: 10.1007/s004150050083 – ident: e_1_3_2_34_2 doi: 10.1161/01.str.0000196987.68770.b3 – ident: e_1_3_2_35_2 doi: 10.1212/WNL.56.5.673 – ident: e_1_3_2_43_2 doi: 10.1093/brain/awh586 – ident: e_1_3_2_8_2 doi: 10.1093/brain/awh223 – ident: e_1_3_2_15_2 doi: 10.1136/jnnp.54.8.683 – ident: e_1_3_2_10_2 doi: 10.1212/01.wnl.0000216271.96364.50 – ident: e_1_3_2_22_2 doi: 10.1161/01.str.0000129643.77045.10 – ident: e_1_3_2_26_2 doi: 10.1212/WNL.43.9.1683 – ident: e_1_3_2_5_2 doi: 10.1212/WNL.51.2.452 – ident: e_1_3_2_36_2 doi: 10.1161/hyp.38.1.110 – ident: e_1_3_2_45_2 doi: 10.1056/NEJMoa051469 – ident: e_1_3_2_13_2 doi: 10.1001/archneur.62.7.1091 – ident: e_1_3_2_19_2 doi: 10.1086/302698 – volume: 27 start-page: 359 year: 2006 ident: e_1_3_2_33_2 publication-title: AJNR Am J Neuroradiol – ident: e_1_3_2_40_2 doi: 10.1161/circulationaha.104.501163 – ident: e_1_3_2_25_2 doi: 10.1161/str.17.6.3810706 – ident: e_1_3_2_18_2 doi: 10.1038/ng786 – ident: e_1_3_2_20_2 doi: 10.1161/str.29.6.1177 – ident: e_1_3_2_9_2 doi: 10.1161/01.str.0000189696.70989.a4 – ident: e_1_3_2_42_2 doi: 10.1073/pnas.0308679101 – ident: e_1_3_2_24_2 doi: 10.1161/str.26.7.1293 – ident: e_1_3_2_44_2 doi: 10.1038/ng1533 – volume: 26 start-page: 2481 year: 2005 ident: e_1_3_2_41_2 publication-title: AJNR Am J Neuroradiol – ident: e_1_3_2_30_2 doi: 10.1007/s004010100439 – ident: e_1_3_2_12_2 doi: 10.1016/S0140-6736(97)08083-5 – ident: e_1_3_2_39_2 doi: 10.1161/str.27.8.1274 – ident: e_1_3_2_29_2 doi: 10.1097/00005072-199709000-00001 – ident: e_1_3_2_23_2 doi: 10.1161/str.28.3.652 – ident: e_1_3_2_3_2 doi: 10.1002/ana.410440506 – ident: e_1_3_2_6_2 doi: 10.1212/WNL.52.7.1361 – ident: e_1_3_2_31_2 doi: 10.1093/brain/awh023 – ident: e_1_3_2_17_2 doi: 10.1006/nimg.2002.1040 – ident: e_1_3_2_32_2 doi: 10.1016/S0021-9150(02)00041-2 – ident: e_1_3_2_38_2 doi: 10.1161/01.str.0000177867.39769.cb – ident: e_1_3_2_21_2 doi: 10.1161/01.hyp.0000112303.26158.92 – ident: e_1_3_2_1_2 doi: 10.1038/383707a0 – ident: e_1_3_2_2_2 doi: 10.1016/S0140-6736(95)91557-5 – ident: e_1_3_2_28_2 doi: 10.1212/WNL.45.5.883 – ident: e_1_3_2_11_2 doi: 10.1161/01.str.0000131546.71733.f1 – ident: e_1_3_2_14_2 doi: 10.1007/s004150050398 – ident: e_1_3_2_7_2 doi: 10.1148/radiol.2293021354 – ident: e_1_3_2_37_2 doi: 10.1161/hyp.39.2.343 – ident: e_1_3_2_4_2 doi: 10.1093/brain/awh282 |
SSID | ssj0002385 |
Score | 2.1379652 |
Snippet | Background and Purpose—
The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with... The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and... BACKGROUND: and Purpose- The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 2684 |
SubjectTerms | Adult Biological and medical sciences Brain - pathology CADASIL - epidemiology CADASIL - genetics CADASIL - pathology Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes Female Humans Investigative techniques, diagnostic techniques (general aspects) Magnetic Resonance Imaging Male Medical sciences Middle Aged Nervous system Nervous system (semeiology, syndromes) Neurology Quantitative Trait, Heritable Radiodiagnosis. Nmr imagery. Nmr spectrometry Receptor, Notch3 Receptors, Notch - genetics Vascular diseases and vascular malformations of the nervous system |
Subtitle | Evidence for Genetic Modifiers |
Title | Heritability of MRI Lesion Volume in CADASIL |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17008614 https://www.proquest.com/docview/19359768 https://www.proquest.com/docview/69021605 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQuM2CmP4gbcpJU4cJ-WtbEAHGxJrJ-0tchxbqtYl0Zpq0n49x5dcNqg0eKmqJHZUf19Ov-OcC0IfuB_SJOIUEFDKo0kOz1weMi_mXMDfbwAaxUT5_mTTM_r9PDofDKpe1NK6zkbi5q95Jf-DKhwDXHWW7D8g204KB-A74AufgDB83gvjqdSuvQlvNS_KT06P9pdS73_tW6tjcvomh5PZ0bFpweNaiJrYQphVJzDqXjgLtXCB8I1OndVX5YWRn2Qc-_3NWF2G4KIrS9Bjlwn1XVl6LVupPi2X9SUvilWl38l_ZrXrBKKThNbtVd_Ayb6WRV67_BsTZ8nv7kmQdk9COjsaUE-nvfYNra3u0hCK9M0ms33i_rTnjJgchdFsfmpKTQYUFCUdgUqKo5Ht19IDuro0SOuagwmzyal3qmk3px6ghwE4FtqU__jV1ZcHARO50rRw64-bb6yLzbqpbimaJxVfwcOlbFeUzW6LkS_zbfTU-R14Ykn0DA1k8Rw9OnGRFS_QcZ9LuFQYuIQtl7BdWLwosOPSJ9wwCQOTsGMSbpn0Ep19_TI_mHqu04YnQMDVnvBlRgVJEnBi8nDMCAcvmZGcS_DewQFlPKaCxdyXlFEVR1kOfngsZOAHItQl-16hraIs5GuEE65YBqo2UiSjlClQQCrLxlpnS8mDfIjGzWqlwpWh191QlqlxRxlJfZLCoqfdoqdm0VPGhihsx1a2GMu9Ru3dAqUbqn8Z6OEhet-glIJx1W_MeCHL9SolOm8dHPLNV8D4gDA_GqIdC283u6PHm41n3qLH3cOzi7bqq7V8BxK3zvYMK38DTlOaTA |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heritability+of+MRI+lesion+volume+in+CADASIL%3A+evidence+for+genetic+modifiers&rft.jtitle=Stroke+%281970%29&rft.au=Opherk%2C+Christian&rft.au=Peters%2C+Nils&rft.au=Holtmannsp%C3%B6tter%2C+Markus&rft.au=Gschwendtner%2C+Andreas&rft.date=2006-11-01&rft.eissn=1524-4628&rft.volume=37&rft.issue=11&rft.spage=2684&rft_id=info:doi/10.1161%2F01.STR.0000245084.35575.66&rft_id=info%3Apmid%2F17008614&rft.externalDocID=17008614 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |